Severe toxicity to capecitabine due to a new variant at a donor splicing site in the dihydropyrimidine dehydrogenase (DPYD) gene

Severe toxicity to capecitabine due to a new variant at a donor splicing site in the dihydropyrimidine dehydrogenase (DPYD) gene

Xandra García-González,1,* Sara López-Tarruella,2,* María Isabel García,1 Eva González-Haba,1 Carolina Blanco,1 Sara Salvador-Martin,1 Yolanda Jerez,2 Fabienne Thomas,3 María Jarama,1 María Sanjurjo Sá...

Full description

Bibliographic Details
Main Authors: García-González X, López-Tarruella S, García MI, González-Haba E, Blanco C, Salvador-Martin S, Jerez Y, Thomas F, Jarama M, Sanjurjo Sáez M, Martín M, López-Fernández LA
Format: Article
Language:English
Published: Dove Medical Press 2018-10-01
Series:Cancer Management and Research
Subjects:
Pharmacogenetics
adverse drug reaction
fluoropyrimidine
breast cancer
Online Access:https://www.dovepress.com/severe-toxicity-to-capecitabine-due-to-a-new-variant-at-a-donor-splici-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/severe-toxicity-to-capecitabine-due-to-a-new-variant-at-a-donor-splici-peer-reviewed-article-CMAR

Similar Items